Monotherapy for the treatment of amyotrophic lateral...

Details Monotherapy for the treatment of amyotrophic lateral... Monotherapy for the treatment of amyotrophic lateral...

A - Human Necessities

61

K

A61K 31/635 (2006.01) A61K 31/00 (2006.01) A61K 31/10 (2006.01) A61K 31/16 (2006.01) A61K 31/18 (2006.01) A61K 31/196 (2006.01) A61K 31/352 (2006.01) A61K 31/365 (2006.01) A61K 31/382 (2006.01) A61K 31/415 (2006.01) A61K 31/421 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61K 31/437 (2006.01) A61K 31/4418 (2006.01) A61K 31/4439 (2006.01) A61K 31/444 (2006.01) A61K 31/47 (2006.01) A61K 31/4745 (2006.01) A61K 31/50 (2006.01) A61K 31/501 (2006.01) A61K 31/519 (2006.01) A61K 31/535 (2006.01) A61K 31/5

Patent

CA 2487923

A method of treating, preventing, or inhibiting ALS, in a subject in need of such treatment, inhibition or prevention. The method comprises administering to a subject one or more cyclooxygenase-2 selective inhibitor(s), or isomer(s), or pharmaceutically acceptable salt(s), ester(s), or prodrug(s) thereof, wherein the amount of the cyclooxygenase-2 selective inhibitor(s), isomer(s), ester(s), salt(s) or prodrug(s) thereof constitutes an ALS treatment, inhibition or prevention effective amount of the COX 2 inhibitor(s).

L'invention concerne une méthode permettant de traiter, prévenir ou inhiber la sclérose amyotrophique latérale (ALS) chez un sujet ayant besoin de traitement, de prévention ou d'inhibition. Ladite méthode consiste à administrer à un sujet un ou plusieurs inhibiteur(s) sélectif(s) de la cyclooxygénase-2, un ou des isomère(s), un ou des sels pharmaceutiquement acceptables, un ou des ester(s) ou un ou des promédicament(s) de ceux-ci. La quantité d'inhibiteurs sélectifs de la cyclooxygénase-2, d'isomère(s), d'ester(s), de sel(s) ou de promédicament(s) de ceux-ci constitue une quantité efficace pour traiter, prévenir ou inhiber l'ALS

Affiliated with

Also associated with

Rating

Monotherapy for the treatment of amyotrophic lateral... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monotherapy for the treatment of amyotrophic lateral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monotherapy for the treatment of amyotrophic lateral... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1757994